Is Candel Therapeutics Stock a good buy in 2024, according to Wall Street analysts?
The consensus among 1 Wall Street analyst covering (NASDAQ: CADL) stock is to Buy CADL stock.
Out of 1 analyst, 0 (0%) are recommending CADL as a Strong Buy, 1 (100%) are recommending CADL as a Buy, 0 (0%) are recommending CADL as a Hold, 0 (0%) are recommending CADL as a Sell, and 0 (0%) are recommending CADL as a Strong Sell.
What is CADL's forecast return on equity (ROE) for 2024-2026?
(NASDAQ: CADL) forecast ROE is N/A, which is considered weak.
What is CADL's Price Target?
According to 1 Wall Street analyst that have issued a 1 year CADL price target, the average CADL price target is $11.00, with the highest CADL stock price forecast at $11.00 and the lowest CADL stock price forecast at $11.00.
The Wall Street analyst predicted that Candel Therapeutics's share price could reach $11.00 by Nov 13, 2024. The average Candel Therapeutics stock price prediction forecasts a potential upside of 71.07% from the current CADL share price of $6.43.
What is CADL's forecast return on assets (ROA) for 2024-2026?
(NASDAQ: CADL) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 8.54%.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.